Randomized dose-escalation designs for drug combination cancer trials with immunotherapy

October 29, 2018, by Pamela Forster

Mozgunov, p., Jaki, T. & Paoletti, X. (2018), Journal of Biopharmaceutical Statistics.

Subgroup identification in clinical trials via the predicted individual treatment effect

October 24, 2018, by Pamela Forster

Ballarini, N., Rosenkranz, G., Jaki, T., König, F. & Posch, M. (2018), PLOS ONE

Quantifying the association between progression‐free survival and overall survival in oncology trials using Kendall’s Tau

October 22, 2018, by Pamela Forster

Weber, E & Titman, A (2018). Statistics in Medicine

Bayesian knowledge integration for an in vitro–in vivo correlation model

October 4, 2018, by Pamela Forster

Erhardt, E., Ursino, M., Biewenga, J & Gasparini, M (2018), Biometrical Journal

A benchmark for dose finding studies with continuous outcomes

August 29, 2018, by Pamela Forster

Mozgunov, P., Jaki, T. & Paoletti, X (2018) Biostatistics